6th Summit on RNAi-based Therapies
January 28th to 30th 2025
Location :
W Boston
100 Stuart St, Boston, MA 02116, United States
Web Site : Home | RNAi-Based Therapeutics Summit
Organizers : Hanson Wade
Welcome to the 6th Summit on RNAi-based Therapies!
Accelerating the Clinical Approval of the Next Wave of RNAi-based Drugs
As innovative drug delivery platforms beyond GalNAc continue to emerge and new chemical modifications are discovered, the potential of RNAi-based therapies to treat a wide range of diseases is increasing. Now more than ever, RNAi therapies are promising for treating diseases beyond the liver and providing effective and tolerable treatment options for patients.
The 6th RNAi-Based Therapeutics Summit returns to Boston to showcase the latest delivery technologies, data from clinically successful extra-hepatic targeting, cutting-edge AI tools for payload design, and revolutionary chemical modifications that enhance stability, enabling precise therapeutic delivery.
Bringing together over 70 leaders in the RNAi field, this summit will allow experts to turn their RNAi candidates into clinically successful therapies. With technical and strategic experts from Novo Nordisk, Alnylam Therapeutics, Judo Bio, Aro Biotherapeutics, Novartis, Comanche Biopharma, and many others, this meeting is a unique gathering of the sharpest minds in RNAi, dedicated to advancing the next wave of RNAi therapies to improve healthcare for patients in need.
